Beware of pancreatic cancer, the king of cancer! Adjunctive emerging chemical drugs aids in improving healing power.

The pancreas and bile duct are situated in the middle of the human abdomen, encircled by significant blood vessels. Lesions that eventually emerge are the much dreaded “biliary tract cancer” and “pancreatic cancer.” On top of it, these tumors cannot be surgically removed because they are often accompanied by blood vessel invasion. Even if they are surgically removed, relapse is a likely occurrence, drastically shortening patients’ survival period.

The therapeutic effects of drugs on pancreatic-biliary cancer have improved in recent years as a result of advancements in anticancer chemical drugs. However, the chances of completely eradicating tumors with anti-cancer drugs alone remain slim.

Currently, surgical removal produces the best results among related treatments. Though not every patient can have cancer removed at the time of diagnosis, with the advancement of anti-cancer chemical drugs in recent years and the introduction of new adjunctive chemotherapy and radiation therapy treatments, there is a chance to beat this difficult-to-treat disease!

【Expert Articles】

Dr. Yang's liver, gallbladder and pancreas surgery world

【Article Report】

Doctors’ Lobby/Gallbladder cancer is not an uncurable disease that there is still a chance of eradicating it by lowering jaundice.
Neoadjuvant therapy increases the likelihood of biliary tract cancer and pancreatic cancer.
Three elements of liver surgery: tumors, liver functions, physical condition.

【Video Interview】

Dr. Yang Bo-Zhi from Fu Jen Catholic University Hospital talks on gallbladder stones.
Director Dr. Yang Bo-Zhi from the Liver Disease Treatment Center, Fu Jen Catholic University Hospital talks on the diagnosis and treatment of liver tumors.
Director Dr. Yang Bo-Zhi from the Liver Disease Treatment Center, Fu Jen Catholic University Hospital talks to all on jaundice.

Bo-Zhi Yang

Director, Organ Transplantation and Liver Disease Treatment Center

Main Info

專家觀點

不怕癌王！「新輔助治療」為肝門膽管癌患者爭取生機

胰臟和肝門膽管是人體中的沉默器官，治療棘手且五年存活率低，因此又被稱為「癌中之王」。不過，目前有「新輔助療法」協助，讓情況出現轉機。

治療癌王兩大新趨勢：精準根治、安全

近年來，因為抗癌化學藥物的進展，藥物對膽胰癌症的治療效果，比以往改善許多，通常醫生會建議手術切除合併化學治療，或搭配新輔助治療如免疫細胞療法。